Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jizu Zhi
Real‐world Progression, Treatment, and Survival Outcomes During Rapid Adoption of Immunotherapy for Advanced Non–small Cell Lung Cancer
Cancer
Cancer Research
Oncology
Real‐World Outcomes of Patients With Metastatic Non‐Small Cell Lung Cancer Treated With Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval
Oncologist
Cancer Research
Medicine
Oncology
Related publications
P2.01-12 Ramucirumab+Docetaxel Usage Following Rapid Disease Progression in Real World Advanced Non-Small Cell Lung Cancer Patients
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Real World Treatment Patterns and Resource Use for Advanced Non-Small Cell Lung Cancer in Brazilian Private Institutions
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Real-World Data on Nivolumab Treatment of Non-Small Cell Lung Cancer
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Potential Role of Immunotherapy in Advanced Non-Small-Cell Lung Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Post-Progression Survival After EGFR-TKI for Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations
PLoS ONE
Multidisciplinary
Pcn61 - Real-World Progression-Free Survival of Patients With Advanced Non-Small Cell Lung Cancer: Results of a Claims Data Study of Patients in Germany
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Maintenance Therapy Improves Survival Outcomes in Patients With Advanced Non-Small Cell Lung Cancer
Lung
Pulmonary
Respiratory Medicine
Latest Immunotherapy Methods in Non-Small Cell Lung Cancer Treatment
Juntendo Medical Journal
Real-World Costs of Laboratory Tests for Non-Small Cell Lung Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
